Author

C. Coulouarn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Alay· 1 shared A. Arabo· 1 shared A. B. Cortot· 1 shared A. Bardelli· 1 shared A. Esteve-Codina· 1 shared A. Guernet· 1 shared A. L'Haridon· 1 shared A. M. Valverde· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Alay

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The hepatocyte Epidermal Growth Factor Receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche

E. Gonzalez-Sanchez, J. Vaquero, D. Caballero-Diaz, J. Grzelak, N. P. Fuste, E. Bertran, J. Amengual, J. Garcia-Saez, B. Martin-Mur, M. Gut, A. Esteve-Codina, A. Alay, C. Coulouarn, S. Calero, P. Valdecantos, , I. Fabregat

This study shows that inhibiting EGFR in hepatocytes reduces liver fibrosis by altering immune cell populations and molecular mechanisms involved in inflammation and fibrogenesis.

bioRxiv · Nov 3, 2023Pathology

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells

L. Brunet, D. Alexandre, J. Lee, M. d. M. Blanquer-Rossello, A. Guernet, H. Chhouri, Z. Kherrouche, A. Arabo, S. Yao, D. Godefroy, J. Dehedin, J.-R. Li, C. Duparc, P. Jamme, A. Vinchent, , L. Grumolato

This study shows that sorafenib can prolong lung cancer response to EGFR inhibitors by targeting resistant cells' selective advantage.

bioRxiv · Jun 19, 2023Cancer Biology

TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma

P. Papoutsoglou, C. Louis, R. Pineau, A. L'Haridon, J. M. Banales, D. Gilot, M. Aubry, C. Coulouarn

This study identifies LINC00313 as a TGFβ-induced lncRNA that activates Wnt signaling and promotes cholangiocarcinoma through interactions with SWI/SNF and regulation of TCF7 and SULF2.

bioRxiv · Sep 28, 2022 · PreprintCancer Biology